SyntheticMR

At Hiroshima University Hospital, SyMRI is used in both research and routine clinical care.
It supports the assessment of patients with neurodegenerative and demyelinating diseases, including ALS, stroke, MS, and dementia.

👉 Discover how it’s used in practice, read the full case study from Hiroshima University Hospital.
https://loom.ly/o_-wT48

👉Dr. Kazufumi Kikuchi and his team at Kyushu University Hospital have demonstrated how qMRI can enhance accuracy, sensitivity, and objectivity in identifying IDH-mutant gliomas. By overcoming the limitations of conventional imaging, qMRI offers a more precise approach to diagnosis, potentially transforming patient outcomes.

Read the full case study here: https://loom.ly/os1yzCg

👉 Attending TSNR 2026 in Dallas?

Meet SyntheticMR and Combinostics and discover how quantitative MRI and AI-driven decision support can enhance accuracy, consistency, and confidence in everyday neuroimaging workflows.

Learn more: https://lnkd.in/dEupkv8g

Advancements in medical imaging are transforming neurological diagnostics, particularly in Multiple Sclerosis (MS).

👉 Discover how hospitals and imaging centers are integrating quantitative MRI into their daily workflows, supporting more accurate diagnosis and consistent monitoring of MS-related changes.

📍 Meet us at ECR to learn how quantitative MR can support clinical decision-making in neuroradiology.